Karyopharm Therapeutics
Anhngan (Anh) Pham has a strong background in the field of Clinical Data Management and programming, with experience working at companies such as Karyopharm Therapeutics Inc., LLX Solutions LLC, and GI Dynamics Inc. Anhngan is a Hood College graduate with a B.A. in Computer Science/Information Systems.
Karyopharm Therapeutics
13 followers
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an innovation-driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).